{
    "clinical_study": {
        "@rank": "70478", 
        "arm_group": [
            {
                "arm_group_label": "Rasagiline", 
                "arm_group_type": "Experimental", 
                "description": "Rasagiline\n1 mg/day; 18 months"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "once daily, 18 months"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of the trial is to investigate the survival time (the time from\n      randomization until death or end of the trial) compared between control group and\n      experimental group.\n\n      This is a prospective, multicenter, randomized, stratified, parallel-group, double-blind\n      trial comparing placebo with 1 mg/d rasagiline as add-on therapy to 100 mg riluzole in\n      amyotrophic lateral sclerosis (ALS) in 250 enrolled patients. For entry, the El Escorial\n      Criteria for the diagnosis of ALS will be used. The patients have to be stable on riluzole\n      at least 4 weeks prior to randomization."
        }, 
        "brief_title": "Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Amyotrophic Lateral Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Sclerosis", 
                "Motor Neuron Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Possible, probable (clinically or laboratory) or definite ALS according to the\n             revised version of the El Escorial World Federation of Neurology criteria\n\n          -  Disease duration more than 6 months and less than 3 years (inclusive). Disease onset\n             defined as date of first muscle weakness, excluding fasciculations and cramps\n\n          -  Vital capacity more than 50% of normal (slow vital capacity; best of three\n             measurements)\n\n          -  Age: \u2265 18 years\n\n          -  Continuously treated with 100 mg riluzole for at least four weeks\n\n          -  Capable of thoroughly understanding all information given and giving full informed\n             consent according to GCP\n\n          -  Women of childbearing age must be non-lactating and surgically sterile or using a\n             highly effective method of birth control and have a negative pregnancy test.\n             Acceptable methods of birth control with a low failure rate i.e. less than 1% per\n             year) when used consistently and correct are such as implants, injectables, combined\n             oral contraceptives, hormonal intrauterine devices (IUDs), or double-barrier methods\n             (condom or diaphragm with spermicidal agent or IUD), sexual abstinence or\n             vasectomized partner\n\n        Exclusion Criteria:\n\n          -  Previous participation in another clinical study within the preceding 12 weeks\n\n          -  Tracheostomy or assisted ventilation of any type during the preceding three months\n\n          -  Gastrostomy\n\n          -  Any medical condition known to have an association with motor neuron dysfunction\n             which might confound or obscure the diagnosis of ALS\n\n          -  Presence of any concomitant life-threatening disease or impairment likely to\n             interfere with functional assessment\n\n          -  Patients on sympathomimetic agents. This includes pseudoephedrine, phenylephrine,\n             phenylpropanolamine, and ephedrine.\n\n          -  Patients on analgesics with serotoninergic properties such as meperidine, tramadol,\n             methadone and propoxyphene.\n\n          -  Patients on serotonin reuptake inhibitors (SSRIs). This includes fluoxetine or\n             fluvoxamine.\n\n          -  Patients on dextromethorphan, St. John's wort, cyclobenzaprine or other MAO\n             inhibitors (selective or non-selective)\n\n          -  Patients taking Antidepressants\n\n          -  Confirmed hepatic insufficiency or abnormal liver function (ASAT and/or ALAT greater\n             than 3 times the upper limit of the normal range)\n\n          -  Renal insufficiency (serum creatinine more than 2.26 mg/dL)\n\n          -  Evidence of major psychiatric disorder or clinically evident dementia precluding\n             evaluation of symptoms\n\n          -  Known hypersensitivity to any component of the study drug\n\n          -  Liable to be not cooperative or comply with the trial requirements (as assessed by\n             the investigator), or unable to be reached in the case of emergency\n\n          -  Female with childbearing potential, if no adequate contraceptive measures are used\n\n          -  Pregnancy or breast-feeding females"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01879241", 
            "org_study_id": "RAS-ALS", 
            "secondary_id": "2011-004482-32"
        }, 
        "intervention": [
            {
                "arm_group_label": "Rasagiline", 
                "intervention_name": "Rasagiline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "a sugar pill manufactured to mimic Rasagiline 1 mg tablet", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Rasagiline"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "amyotrophic lateral sclerosis", 
            "survival time", 
            "ALS functioning Rating Scale", 
            "quality of life", 
            "survival"
        ], 
        "lastchanged_date": "August 20, 2013", 
        "location": [
            {
                "contact": {
                    "email": "albert.ludolph@rku.de", 
                    "last_name": "Albert C Ludolph, MD, Prof.", 
                    "phone": "+49-731-177-", 
                    "phone_ext": "1200"
                }, 
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "state": "Baden-W\u00fcrttemberg", 
                        "zip": "89081"
                    }, 
                    "name": "Department of Neurology, University of Ulm"
                }, 
                "investigator": {
                    "last_name": "Albert C Ludolph, MD, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drawinkler@yahoo.com.au", 
                    "last_name": "Andrea Winkler, Prof. Dr.", 
                    "phone": "+49 89 - 4140", 
                    "phone_ext": "4630"
                }, 
                "facility": {
                    "address": {
                        "city": "Muenchen", 
                        "country": "Germany", 
                        "state": "Bayern", 
                        "zip": "D-81675"
                    }, 
                    "name": "Department of Neurology, Technische Universit\u00e4t M\u00fcnchen"
                }, 
                "investigator": {
                    "last_name": "Andrea Winkler, Dr. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "wilhelm.schulte-mattler@klinik.uni-regensburg.de", 
                    "last_name": "Wilhelm Schulte-Mattler, Prof. Dr.", 
                    "phone": "+49-941-941", 
                    "phone_ext": "0"
                }, 
                "facility": {
                    "address": {
                        "city": "Regensburg", 
                        "country": "Germany", 
                        "state": "Bayern", 
                        "zip": "D-93053"
                    }, 
                    "name": "Department of Neurology, Universty of Regensburg"
                }, 
                "investigator": {
                    "last_name": "Wilhelm Schulte-Mattler, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Klebe_S@klinik.uni-wuerzburg.de", 
                    "last_name": "Klebe Stephan, PD Dr.", 
                    "phone": "+49-931-201-", 
                    "phone_ext": "5750"
                }, 
                "facility": {
                    "address": {
                        "city": "Wuerzburg", 
                        "country": "Germany", 
                        "state": "Bayern", 
                        "zip": "91054"
                    }, 
                    "name": "Department of Neurology, University of Wuerzburg"
                }, 
                "investigator": {
                    "last_name": "Stephan Klebe, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "schrank.neuro@dkd-wiesbaden.de", 
                    "last_name": "Bertold Schrank, Dr.", 
                    "phone": "+49-611-577", 
                    "phone_ext": "431"
                }, 
                "facility": {
                    "address": {
                        "city": "Wiesbaden", 
                        "country": "Germany", 
                        "state": "Hessen", 
                        "zip": "D-65191"
                    }, 
                    "name": "Department of Neurology, Deutsche Klinik f\u00fcr Diagnostik"
                }, 
                "investigator": {
                    "last_name": "Bertold Schrank, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "johannes.prudlo@med.uni-rostock.de", 
                    "last_name": "Johannes Prudlo, PD Dr.", 
                    "phone": "+49-381-494", 
                    "phone_ext": "4742"
                }, 
                "facility": {
                    "address": {
                        "city": "Rostock", 
                        "country": "Germany", 
                        "state": "Mecklenburg-Vorpommern", 
                        "zip": "D-18147"
                    }, 
                    "name": "Department of Neurology, University of Rostock"
                }, 
                "investigator": {
                    "last_name": "Johannes Prudlo, PD Dr.", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jochen.weishaupt@medizin.uni.goettingen.de", 
                    "last_name": "Bettina G\u00f6ricke, Dr.", 
                    "phone": "+49-551-39", 
                    "phone_ext": "12581"
                }, 
                "facility": {
                    "address": {
                        "city": "Goettingen", 
                        "country": "Germany", 
                        "state": "Niedersachsen", 
                        "zip": "D-37073"
                    }, 
                    "name": "Department of Neurology, University of Goettingen"
                }, 
                "investigator": {
                    "last_name": "Bettina G\u00f6ricke, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Petri.Susanne@mh-hannover.de", 
                    "last_name": "Susanne Petri, Prof. Dr.", 
                    "phone": "+49-511-532-", 
                    "phone_ext": "3740"
                }, 
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "state": "Niedersachsen", 
                        "zip": "30625"
                    }, 
                    "name": "Department of Neurology, Medical School Hannover"
                }, 
                "investigator": {
                    "last_name": "Susanne Petri, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Torsten.Grehl@rub.de", 
                    "last_name": "Torsten Grehl, MD", 
                    "phone": "+49-234-302-", 
                    "phone_ext": "6812"
                }, 
                "facility": {
                    "address": {
                        "city": "Bochum", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen", 
                        "zip": "44789"
                    }, 
                    "name": "Neurologische Universit\u00e4tsklinik Bergmannsheil"
                }, 
                "investigator": {
                    "last_name": "Torsten Grehl, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "young@uni-muenster.de", 
                    "last_name": "Matthias B\u00f6ntert, Dr.", 
                    "phone": "+49-251-83", 
                    "phone_ext": "47955"
                }, 
                "facility": {
                    "address": {
                        "city": "Muenster", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen", 
                        "zip": "D-48149"
                    }, 
                    "name": "Department of Neurology, Universty of Muenster"
                }, 
                "investigator": {
                    "last_name": "Matthias B\u00f6ntert, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "michael.heneka@ukb.uni-bonn.de", 
                    "last_name": "Michael T. Heneka, Prof. Dr.", 
                    "phone": "+49-228-287", 
                    "phone_ext": "13092"
                }, 
                "facility": {
                    "address": {
                        "city": "Bonn", 
                        "country": "Germany", 
                        "state": "Nordrhrein-Westfalen", 
                        "zip": "D-53105"
                    }, 
                    "name": "Department of Neurology, Universty of Bonn"
                }, 
                "investigator": {
                    "last_name": "Michael T. Heneka, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "frank.hanisch@medizin.uni-halle.de", 
                    "last_name": "Frank Hanisch, Dr.", 
                    "phone": "+49-345-557-", 
                    "phone_ext": "3340"
                }, 
                "facility": {
                    "address": {
                        "city": "Halle/Saale", 
                        "country": "Germany", 
                        "state": "Sachsen-Anhalt", 
                        "zip": "06097"
                    }, 
                    "name": "Department of Neurology, University of Halle-Wittenberg"
                }, 
                "investigator": {
                    "last_name": "Frank Hanisch, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "alexander.storch@neuro.med.tu-dresden.de", 
                    "last_name": "Andreas Hermann, Dr.", 
                    "phone": "+49-351-458", 
                    "phone_ext": "2532"
                }, 
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany", 
                        "state": "Sachsen", 
                        "zip": "D-01307"
                    }, 
                    "name": "Department of Neurology, TU Dresden"
                }, 
                "investigator": {
                    "last_name": "Andreas Hermann, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "julian.grosskreutz@med.uni-jena.de", 
                    "last_name": "Julian Grosskreutz, PD Dr.", 
                    "phone": "+49-3641-932", 
                    "phone_ext": "3426"
                }, 
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany", 
                        "state": "Thueringen", 
                        "zip": "D-07747"
                    }, 
                    "name": "Department of Neurology, University of Jena"
                }, 
                "investigator": {
                    "last_name": "Julian Grosskreutz, PD Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "thomas.meyer@charite.de", 
                    "last_name": "Thomas Meyer, MD, Prof.", 
                    "phone": "+49-30-450560-", 
                    "phone_ext": "032"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Department of Neurology, Humboldt University"
                }, 
                "investigator": {
                    "last_name": "Thomas Meyer, MD, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy, Safety and Tolerability Study of 1 mg Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) Receiving Standard Therapy (Riluzole) - An AMG Trial With a Market Authorized Substance", 
        "overall_contact": {
            "email": "albert.ludolph@rku.de", 
            "last_name": "Albert C Ludolph, MD, Prof.", 
            "phone": "+49-731-177", 
            "phone_ext": "1200"
        }, 
        "overall_official": {
            "affiliation": "Department of Neurology, University of Ulm", 
            "last_name": "Albert C. Ludolph, MD, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Survival in ALS-Patients with Rasagiline compared to placebo", 
            "safety_issue": "Yes", 
            "time_frame": "18 Months"
        }, 
        "reference": {
            "PMID": "15372249", 
            "citation": "Waibel S, Reuter A, Malessa S, Blaugrund E, Ludolph AC. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model. J Neurol. 2004 Sep;251(9):1080-4."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01879241"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Ulm", 
            "investigator_full_name": "Albert Christian Ludolph, Prof.", 
            "investigator_title": "MD, Prof.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change of total score of ALS Functional Rating Scale - Revised (ALSFRS-R)", 
                "safety_issue": "No", 
                "time_frame": "18 Months"
            }, 
            {
                "measure": "Change of individual Quality of Life (SEIQoL, Schedule for the Evaluation of Individual Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "18 Months"
            }, 
            {
                "measure": "Change of slow vital capacity", 
                "safety_issue": "No", 
                "time_frame": "18 Months"
            }
        ], 
        "source": "University of Ulm", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Ulm", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}